Suchergebnisse - "Zheng, Lin"

PubPharm (10)

1

Tumor priming using metronomic chemotherapy with neovasculature-targeted, nanoparticulate paclitaxel

enthalten in: Biomaterials | 2016

von Luan, X. | Guan, Y. | Lovell, J. | +11

2

DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding

enthalten in: Biomaterials | 2016

von Li, C. | Zheng, L. | Yang, X. | +6

3

DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding

enthalten in: Biomaterials | 2016

von Zheng, L. | Luo, L. | Wu, W. | +6

4

Tumor priming using metronomic chemotherapy with neovasculature-targeted, nanoparticulate paclitaxel

enthalten in: Biomaterials | 2016

von Luan, X. | Guan, Y. | Lovell, J. | +11

5

Development of a gene/drug dual delivery system for brain tumor therapy : potent inhibition via RNA interference and synergistic effects

enthalten in: Biomaterials | 2013

von Lei, C. | Cui, Y. | Zheng, L. | +2

6

Development of a gene/drug dual delivery system for brain tumor therapy: Potent inhibition via RNA interference and synergistic effects

enthalten in: Biomaterials | 2013

von Lei, C. | Cui, Y. | Zheng, L. | +2

7

Bioimaging and toxicity assessments of near-infrared upconversion luminescent NaYF4:Yb,Tm nanocrystals

enthalten in: Biomaterials | 2011

von Zhou, J. | Yang, Z. | Dong, W. | +3

8

Bioimaging and toxicity assessments of near-infrared upconversion luminescent NaYF4:Yb,Tm nanocrystals

enthalten in: Biomaterials | 2011

von Zhou, J. | Yang, Z. | Dong, W. | +3

9

The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice

enthalten in: Biomaterials | 2010

von Ranganath, S. | Fu, Y. | Arifin, D. | +5

10

The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice

enthalten in: Biomaterials | 2010

von Ranganath, S. | Fu, Y. | Arifin, D. | +5

1
[1]